Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

pilott

Nil


Contact Details:
Tel:
Fax:
Email:
WWW:

www.pilott.com/




Recent Publications by pilott:

Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial.
BACKGROUND: Leukotriene inhibitors and leukotriene-receptor antagonists...
9th August, 2003
Department of Research and Development, Pilot Therapeutics Inc., Clin Ther. 2003 Mar;25(3):972-9.
Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects.
BACKGROUND: Numerous studies have explored dietary-management strategies...
9th August, 2003
Department of Research and Development, Pilot Therapeutics Inc., Clin Ther. 2003 Mar;25(3):948-71.
Interaction of low molecular weight group IIA phospholipase A2 with apoptotic human T cells: role of heparan sulfate proteoglycans.
Human group IIA phospholipase A2 (hIIA PLA2) is a 14 kDa secreted enzyme...
26th June, 2003
Pilot Therapeutics Inc., 2000 Daniel Island Dr., Suite 440, Charleston, SC FASEB J. 2003 Jun;17(9):1068-80.
DOI Direct Link

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 131 times since April 2007, the link to the organisation's website has been followed 35 times



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for pilott

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.